Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Ayala Pharmaceuticals
What is the target price for Ayala Pharmaceuticals (ADXS)?
The latest price target for Ayala Pharmaceuticals (OTCQX: ADXS) was reported by Ladenburg Thalmann on May 30, 2023. The analyst firm set a price target for $4.00 expecting ADXS to rise to within 12 months (a possible 325.53% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ayala Pharmaceuticals (ADXS)?
The latest analyst rating for Ayala Pharmaceuticals (OTCQX: ADXS) was provided by Ladenburg Thalmann, and Ayala Pharmaceuticals upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Ayala Pharmaceuticals (ADXS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ayala Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ayala Pharmaceuticals was filed on May 30, 2023 so you should expect the next rating to be made available sometime around May 30, 2024.
Is the Analyst Rating Ayala Pharmaceuticals (ADXS) correct?
While ratings are subjective and will change, the latest Ayala Pharmaceuticals (ADXS) rating was a upgraded with a price target of $0.00 to $4.00. The current price Ayala Pharmaceuticals (ADXS) is trading at is $0.94, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.